Jason Bednar
Stock Analyst at Piper Sandler
(2.23)
# 2,769
Out of 5,113 analysts
193
Total ratings
41.5%
Success rate
-3.02%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Overweight | $50 | $44.84 | +11.51% | 1 | Jan 12, 2026 | |
| SHC Sotera Health Company | Upgrades: Overweight | $17 → $24 | $18.59 | +29.10% | 4 | Jan 9, 2026 | |
| COO The Cooper Companies | Reiterates: Overweight | $83 → $94 | $80.90 | +16.19% | 15 | Dec 5, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Neutral | $200 → $190 | $203.42 | -6.60% | 11 | Nov 7, 2025 | |
| ICUI ICU Medical | Maintains: Overweight | $153 → $172 | $152.86 | +12.52% | 3 | Nov 7, 2025 | |
| SOLV Solventum | Maintains: Overweight | $94 → $98 | $79.01 | +24.03% | 8 | Nov 7, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Overweight | $105 → $109 | $82.55 | +32.04% | 14 | Oct 31, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $190 → $200 | $167.65 | +19.30% | 32 | Oct 30, 2025 | |
| KRMD KORU Medical Systems | Maintains: Neutral | $3.5 → $4 | $5.63 | -28.89% | 8 | Aug 7, 2025 | |
| MASI Masimo | Maintains: Overweight | $200 → $210 | $140.20 | +49.79% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $19 | $24.05 | -21.00% | 13 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $9 → $2.5 | $1.80 | +39.28% | 12 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $13.26 | +156.41% | 11 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $12.72 | +25.79% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $77.59 | -0.76% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $4.09 | +10.02% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $263.13 | +0.71% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $3.71 | +61.73% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $7.33 | -4.50% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $20 | $1.46 | +1,269.86% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $528.81 | -29.65% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $80.27 | +18.35% | 1 | Apr 19, 2023 |
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.84
Upside: +11.51%
Sotera Health Company
Jan 9, 2026
Upgrades: Overweight
Price Target: $17 → $24
Current: $18.59
Upside: +29.10%
The Cooper Companies
Dec 5, 2025
Reiterates: Overweight
Price Target: $83 → $94
Current: $80.90
Upside: +16.19%
Becton, Dickinson and Company
Nov 7, 2025
Maintains: Neutral
Price Target: $200 → $190
Current: $203.42
Upside: -6.60%
ICU Medical
Nov 7, 2025
Maintains: Overweight
Price Target: $153 → $172
Current: $152.86
Upside: +12.52%
Solventum
Nov 7, 2025
Maintains: Overweight
Price Target: $94 → $98
Current: $79.01
Upside: +24.03%
Merit Medical Systems
Oct 31, 2025
Reiterates: Overweight
Price Target: $105 → $109
Current: $82.55
Upside: +32.04%
Align Technology
Oct 30, 2025
Reiterates: Overweight
Price Target: $190 → $200
Current: $167.65
Upside: +19.30%
KORU Medical Systems
Aug 7, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $5.63
Upside: -28.89%
Masimo
Aug 6, 2025
Maintains: Overweight
Price Target: $200 → $210
Current: $140.20
Upside: +49.79%
Aug 1, 2025
Maintains: Neutral
Price Target: $17 → $19
Current: $24.05
Upside: -21.00%
Jul 31, 2025
Downgrades: Neutral
Price Target: $9 → $2.5
Current: $1.80
Upside: +39.28%
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $13.26
Upside: +156.41%
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $12.72
Upside: +25.79%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $77.59
Upside: -0.76%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $4.09
Upside: +10.02%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $263.13
Upside: +0.71%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $3.71
Upside: +61.73%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $7.33
Upside: -4.50%
Aug 7, 2024
Maintains: Overweight
Price Target: $70 → $20
Current: $1.46
Upside: +1,269.86%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $528.81
Upside: -29.65%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $80.27
Upside: +18.35%